| A Phase I Study of AG-348 in Healthy Volunteers (NCT02149966) | Agios Pharmaceuticals, Inc. | 2014-05-01 |
| Effects of Transcranial Magnetic Stimulation (TMS) on Somatosensory Perception (NCT02119637) | National Center for Complementary and Integrative Health (NCCIH) | 2014-04-17 |
| A Study of the Effect of Formulation and Tablet Hardness on the Bioavailability of Pictilisib in Healthy Volunteers (NCT02092831) | Genentech, Inc. | 2014-04-01 |
| A Randomized, Phase I, Cross-Over Study to Assess the Relative Bioavailability of Single-Dose Cobimetinib (GDC-0973) in Tablet vs. Capsule Formulation (NCT02136524) | Genentech, Inc. | 2014-04-01 |
| A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval (NCT02104648) | Hoffmann-La Roche | 2014-04-01 |
| A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy Volunteers (NCT02133937) | Hoffmann-La Roche | 2014-04-01 |
| A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers. (NCT02019290) | Hoffmann-La Roche | 2014-02-10 |
| Bioequivalence Study of Denosumab CP4 Drug Product and Commercially Available Denosumab CP2 Drug Product (NCT02053753) | Amgen | 2014-02-01 |
| A Study Evaluating the Effect of Formulation on the Bioavailability of Ipatasertib in Healthy Volunteers (NCT02063581) | Genentech, Inc. | 2014-02-01 |
| A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy Volunteers (NCT02074553) | Hoffmann-La Roche | 2014-02-01 |
| Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults (NCT02100917) | Meiji Seika Pharma Co., Ltd. | 2014-01-01 |
| Links Between Inflammation and Cardiometabolic Diseases (NCT01934660) | National Heart, Lung, and Blood Institute (NHLBI) | 2013-12-02 |
| A Study of the Effects of Posaconazole on Alectinib (RO5424802) Pharmacokinetics in Healthy Volunteers (NCT01984229) | Hoffmann-La Roche | 2013-12-01 |
| A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of RO6864018 in Male, Healthy, Asian Participants (NCT02015715) | Hoffmann-La Roche | 2013-12-01 |
| A Study Investigating the Effect of Food and Esomeprazole on the Single Oral Dose Pharmacokinetics of Alectinib (RO5424802) in Healthy Volunteers. (NCT02023125) | Hoffmann-La Roche | 2013-12-01 |
| A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model (NCT01980966) | Genentech, Inc. | 2013-11-25 |
| A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy Volunteers (NCT01980953) | Genentech, Inc. | 2013-11-01 |
| A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers (NCT01967966) | Genentech, Inc. | 2013-11-01 |
| A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With Food (NCT01969266) | Janssen Research & Development, LLC | 2013-10-01 |
| A Study of the Effect of Multiple Doses of Itraconazole and Fluoxetine on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy Subjects (NCT01967979) | Hoffmann-La Roche | 2013-10-01 |
| A Study of RO6870868 in Healthy Volunteers (NCT01911611) | Hoffmann-La Roche | 2013-08-01 |
| A Screening Study To Assess The Cognition Status in Healthy Volunteers (NCT01926873) | Hoffmann-La Roche | 2013-08-01 |
| A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers (NCT01877785) | Genentech, Inc. | 2013-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects (NCT02176252) | Ardelyx | 2013-07-01 |
| A Study of RO6799477 in Healthy Volunteers (NCT01893437) | Hoffmann-La Roche | 2013-07-01 |
| Color Vision as a Measure for Inherited Retinal Diseases (NCT01878032) | National Eye Institute (NEI) | 2013-06-03 |
| A Study of Single Dose Inclacumab in Japanese Healthy Volunteers Compared to Caucasian Healthy Volunteers (NCT01815827) | Hoffmann-La Roche | 2013-06-01 |
| A Study of Three Modified-Release Formulations of RO4917523 in Healthy Volunteers (NCT01873508) | Hoffmann-La Roche | 2013-06-01 |
| A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 in Healthy Volunteers (NCT01864226) | Hoffmann-La Roche | 2013-06-01 |
| Validation of a Portable Medical Device for Diagnostic in Vitro (NCT02843958) | University Hospital, Grenoble | 2013-06-01 |
| A Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy Participants (NCT01866033) | Janssen Research & Development, LLC | 2013-06-01 |
| A Study of RO4995819 to Assess Bioavailability and Safety in Healthy Volunteers (NCT01901159) | Hoffmann-La Roche | 2013-06-01 |
| Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous Dose (NCT01869686) | Amgen | 2013-06-01 |
| Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research (NCT01851382) | National Cancer Institute (NCI) | 2013-05-15 |
| A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers (NCT01870245) | Achaogen, Inc. | 2013-05-01 |
| A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy Volunteers (NCT01802853) | Hoffmann-La Roche | 2013-05-01 |
| A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers (NCT01814709) | Genentech, Inc. | 2013-04-01 |
| Intranasal AD4-H5-VTN as an Adenovirus Vaccine (NCT01806909) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-06 |
| A School-based Education Programme to Reduce Salt Intake in Children and Their Families (NCT01821144) | Queen Mary University of London | 2013-03-01 |
| A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetics of Vismodegib (NCT01772290) | Genentech, Inc. | 2013-02-01 |
| Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C (NCT01760187) | Aegerion Pharmaceuticals, Inc. | 2012-11-07 |
| A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer (NCT01992601) | Yuhan Corporation | 2012-11-01 |
| A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy Volunteers (NCT01708616) | Hoffmann-La Roche | 2012-11-01 |
| A Safety And Pharmacokinetic Study of Setrobuvir Alone and In Combination With Ritonavir-Boosted Danoprevir in Subjects With Mild Hepatic Impairment Compared to Healthy Controls (NCT01714154) | Hoffmann-La Roche | 2012-11-01 |
| A Pharmacokinetic Study of Aleglitazar in Healthy Chinese Volunteers (NCT01711775) | Hoffmann-La Roche | 2012-11-01 |
| Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis) (NCT01568697) | National Institute of Dental and Craniofacial Research (NIDCR) | 2012-10-05 |
| A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy Volunteers (NCT01711801) | Hoffmann-La Roche | 2012-10-01 |
| A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers (NCT01701739) | Hoffmann-La Roche | 2012-10-01 |
| Normal Values in Hearing and Balance Testing (NCT01629108) | National Institute on Deafness and Other Communication Disorders (NIDCD) | 2012-09-21 |
| A Study of Single Dose RO6811135 in Healthy Volunteers (NCT01676584) | Hoffmann-La Roche | 2012-09-01 |
| A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers (NCT01684891) | Hoffmann-La Roche | 2012-09-01 |
| A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers (NCT01711762) | Genentech, Inc. | 2012-09-01 |
| A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets (NCT01697436) | Hoffmann-La Roche | 2012-09-01 |
| A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy Volunteers (NCT01679639) | Hoffmann-La Roche | 2012-08-01 |
| Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men (NCT01674036) | Genzyme, a Sanofi Company | 2012-08-01 |
| A Study of the Relative Bioavailability of Single Dose RO4917838 and the Effect of Food in Healthy Volunteers (NCT01665976) | Hoffmann-La Roche | 2012-08-01 |
| Estimating Brain Biomechanics Using MRI (NCT01633268) | National Institutes of Health Clinical Center (CC) | 2012-07-04 |
| A Study of the Effect of Fluvoxamine on the Pharmacokinetics of RO4917523 in Healthy Volunteers (NCT01665404) | Hoffmann-La Roche | 2012-07-01 |
| A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers (NCT01615354) | Hoffmann-La Roche | 2012-07-01 |
| A Study of The Effects of Multiple Doses of Ketoconazole on Single Dose Pharmacokinetics of RO4602522 in Healthy Male Volunteers (NCT01625806) | Hoffmann-La Roche | 2012-07-01 |
| A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers (NCT01654211) | Hoffmann-La Roche | 2012-07-01 |
| A Single-Center Study of RO5508887 in Healthy Volunteers (NCT01664143) | Hoffmann-La Roche | 2012-07-01 |
| A Relative Bioavailability Study of Setrobuvir Tablet Formulation Versus Reference Setrobuvir Capsule Formulation in Healthy Volunteers (NCT01612143) | Hoffmann-La Roche | 2012-06-01 |
| A Single Dose Study of Radiolabeled RO4602522 in Healthy Volunteers (NCT01631422) | Hoffmann-La Roche | 2012-06-01 |
| Caloric Stimulation on Cerebral Blood Flow (NCT01629901) | Duke University | 2012-06-01 |
| A Study of the Effect of Carbamazepine on the Pharmacokinetics of RO4917523 in Healthy Volunteers (NCT01629368) | Hoffmann-La Roche | 2012-06-01 |
| A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy Volunteers (NCT01592318) | Hoffmann-La Roche | 2012-05-01 |
| A Pharmacodynamic and Pharmacokinetic Study of RO5508887 in Healthy Volunteers (NCT01592331) | Hoffmann-La Roche | 2012-05-01 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers (NCT01597947) | Achaogen, Inc. | 2012-05-01 |
| A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers (NCT01592890) | Hoffmann-La Roche | 2012-04-01 |
| A Study of Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir in Healthy Volunteers (NCT01588002) | Hoffmann-La Roche | 2012-04-01 |
| A Study of LY110140 in Healthy Japanese Male Participants (NCT01569126) | Eli Lilly and Company | 2012-04-01 |
| Brain Bases of Natural Scenes's Visual Perception of Natural Scenes (NCT02840305) | University Hospital, Grenoble | 2012-04-01 |
| A Study of MCAF5352A in Healthy Volunteers (NCT01540760) | Genentech, Inc. | 2012-03-01 |
| A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine Clearance (NCT01556633) | Hoffmann-La Roche | 2012-03-01 |
| A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers (NCT01543529) | Hoffmann-La Roche | 2012-02-28 |
| Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Adults (NCT01634178) | Amgen | 2012-02-01 |
| A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers (NCT01519336) | Hoffmann-La Roche | 2012-02-01 |
| Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy Adults (NCT01634191) | Amgen | 2012-02-01 |
| A Study of RG7667 in Healthy Volunteers (NCT01496755) | Genentech, Inc. | 2012-01-01 |
| Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects (NCT01487239) | Genentech, Inc. | 2011-12-01 |
| A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers (NCT01514968) | Hoffmann-La Roche | 2011-12-01 |
| A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects (NCT01461460) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2011-11-28 |
| A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers (NCT01620931) | Hoffmann-La Roche | 2011-11-07 |
| Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980 (NCT01473316) | Genentech, Inc. | 2011-11-01 |
| A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy Volunteers (NCT01495104) | Hoffmann-La Roche | 2011-10-01 |
| A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug Users (NCT01438749) | Hoffmann-La Roche | 2011-10-01 |
| Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects (NCT01474668) | Genentech, Inc. | 2011-10-01 |
| A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects (NCT01452542) | Genzyme, a Sanofi Company | 2011-10-01 |
| A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers (NCT01476267) | Hoffmann-La Roche | 2011-10-01 |
| A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838 (NCT01510899) | Hoffmann-La Roche | 2011-10-01 |
| A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers (NCT01591850) | Hoffmann-La Roche | 2011-09-01 |
| Influence of Emotion in a Test Run Forgetfulness (NCT02547259) | Centre Hospitalier Universitaire de Saint Etienne | 2011-09-01 |
| A Pharmacokinetic Study of RO4917838 in Healthy Chinese Volunteers (NCT01433575) | Hoffmann-La Roche | 2011-09-01 |
| A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy Volunteers (NCT01461967) | Hoffmann-La Roche | 2011-09-01 |
| Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects (NCT01414881) | Kastle Therapeutics, LLC | 2011-09-01 |
| A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese Descent (NCT01579149) | Genzyme, a Sanofi Company | 2011-09-01 |
| A Study of RO5267683 in Healthy Subjects (NCT01398241) | Hoffmann-La Roche | 2011-08-01 |
| A Study of Danoprevir in Combination With Low-Dose Ritonavir in Healthy Subjects (NCT01398293) | Hoffmann-La Roche | 2011-08-01 |
| A Study of Lebrikizumab in Healthy Japanese and Caucasian Volunteers (NCT01423318) | Genentech, Inc. | 2011-08-01 |